HOME >> BIOLOGY >> NEWS
Whitaker Foundation funds Washington University biomedical engineering facility

me a national leader in an important field that is bringing to the world breakthroughs in human health every day."

"We are extremely pleased to have the support of The Whitaker Foundation to build a world-class biomedical engineering department," stated Frank C.P. Yin, M.D., Ph.D., chair of the department and director of the university's Institute of Biological and Medical Engineering. (Yin also is Steven F. and Camilla T. Brauer Professor of Biomedical Engineering.) "We will be recruiting a mix of outstanding senior and junior faculty. Once the building and the new faculty are in place, we will be more than ready to meet the demand for biomedical engineering, which already is extremely popular with our students."

Christopher I. Byrnes, dean of the School of Engineering and Applied Sciences, said this high demand was anticipated early on in the planning for the 21st century. "The need for a strong biomedical engineering department was identified as one of the school's top priorities during our Project 21 planning process," Byrnes noted.

Recognizing the need to begin building a biomedical engineering center, the new department was introduced in the fall of 1997, with 50 freshman students expressing an interest in a major. This fall, nearly one-third of the 270 incoming engineering freshmen have declared an interest in the biomedical engineering major. Roughly half of the engineering students earning a bachelor's degree pursue a medical degree, with the other half going into industry or academia. The department currently enrolls 29 graduate students, 19 doctoral candidates and 10 master's degree students.

"The Biomedical Engineering department has been growing steadily, with the resulting growing pains," said Byrnes. "The Foundation's awards will transform the young department with limited space into a major center of research and teaching."

While the young department is small, with a core faculty of five full-time
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
4-Nov-1999


Page: 1 2 3 4

Related biology news :

1. Whitaker Foundation to phase out grant programs
2. UC Davis biomedical engineering department awarded $12 million by Whitaker Foundation
3. Whitaker makes largest individual grants ever totaling more than $30 million
4. Whitaker Foundation To Fund AAAS Science Journalism Awards Through 2001
5. Whitaker Awards $6.8 Million For Biomedical Engineering Education
6. Brown ecologist garners major National Science Foundation grant
7. APS Foundation names student travel award recipients
8. Institute for OneWorld Health receives Gates Foundation grant
9. National Parkinson Foundation designates UNC as Center of Excellence
10. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
11. Leslie Ann Schiff wins 2004 Carski Foundation Award

Post Your Comments:
(Date:10/16/2014)... conventional thinking on how the bowel lining develops and, ... bowel cancer starts. , The researchers produced evidence that ... ,crypts, that are a feature of the bowel lining, ... cancer development, a controversial finding as scientists are still ... imaging technologies, Dr Chin Wee Tan and Professor Tony ...
(Date:10/16/2014)... Syncytial Virus causes severe respiratory tract infections and ... year. Scientists at VIB and Ghent University have ... counteract this common virus infection. , Xavier ... that paves the way for the development of ... virus that causes suffering in numerous small children ...
(Date:10/16/2014)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market announces ... the Smart Wallet, at the 13 th annual ... global conference on the intersection of technology and the ... , founder and publisher of the Strategic News Service™, ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2New perspectives for development of an RSV vaccine 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
(Date:10/22/2014)... BOSTON , Oct. 22, 2014 /PRNewswire/ ... global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, ... option to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, ... agonist, for the treatment of diabetic gastroparesis and other ... a successful Phase 2 trial of relamorelin for the ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider ... with a team of researchers from Yale University’s School ... Collaborative to provide electronic questionnaire data collection through use ... started in May, aims to evaluate the impact of ... to and participation in urban agriculture to impact their ...
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, announced today ... a Notice of Allowance for a composition of matter ... C. difficile program, SYN-004. This is Synthetic Biologics, ... the U.S. and adds to the Company,s extensive ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
Cached News: